Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF + R-CHOP in Relapsed/Refractory PCNSL
NCT03536039Phase 2Completed
- Start
- Jan 2016
- Primary completion
- Jan 2019
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of NGR-TNF in primary central nervous system lymphoma (PCNSL). Started Jan 2016; status: completed.
02
Drugs
NGR-TNF
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT03536039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03536039.